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Hazardous drinking among young adults 
seeking outpatient mental health services
Anna E. Ordóñez1,3*, Rachel Ranney1, Maxine Schwartz1, Carol A. Mathews1,4 and Derek D. Satre1,2
Abstract 
Background: Alcohol use can have a significant negative impact on young adults in mental health treatment. This 
cross-sectional study examined prevalence and factors associated with hazardous drinking among young adults seek-
ing outpatient mental health services, rate of alcohol use disorders (AUDs), and the relationship between hazardous 
drinking and other types of substance use.
Methods: Participants were 487 young adults ages 18–25 who completed self-administered computerized screen-
ing questions for alcohol and drug use. Alcohol use patterns were assessed and predictors of hazardous drinking (≥5 
drinks on one or more occasions in the past year) were identified using logistic regression.
Results: Of the 487 participants, 79.8 % endorsed prior-year alcohol use, 52.3 % reported one or more episodes of 
hazardous drinking in the prior year and 8.2 % were diagnosed with an AUD. Rates of recent and lifetime alcohol, 
tobacco and marijuana use were significantly greater in those with prior-year hazardous drinking. In logistic regres-
sion, prior-year hazardous drinking was associated with lifetime marijuana use (OR 3.30, p < 0.001; 95 % CI 2.05, 5.28), 
lifetime tobacco use (OR 1.88, p = 0.004; 95 % CI 1.22, 2.90) and older age (OR 1.18 per year, p < 0.001; 95 % CI 1.08, 
1.29).
Conclusions: In an outpatient mental health setting, high rates of hazardous drinking were identified, and drinking 
was associated with history of other substance use. Results highlight patient characteristics associated with hazardous 
drinking that mental health providers should be aware of in treating young adults, especially older age and greater 
use of tobacco and marijuana.
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Background
Substance use disorders, hazardous drinking and men-
tal illness all peak in prevalence in early adulthood, yet 
few young adults receive appropriate services. For exam-
ple, the 2011 National Household Survey on Drug Use 
and Health (NHSDUH) found that the 1-year prevalence 
of illicit drug or alcohol abuse or dependence increased 
from 7 % among 12–17 year olds to 19 % for 18–25 year 
olds, decreasing to 6  % for individuals over 25 [1]. The 
same report found that adults ages 18–25 had higher 
rates of mental illness and were less likely to receive treat-
ment in the prior year than older adults.
Alcohol use can adversely impact symptom sever-
ity and treatment of co-occurring mental illness [2–5]. 
Reduced response to antidepressants and increased risk 
of side effects have been reported with even moderate 
levels of alcohol use [5]. In the STAR*D depression treat-
ment cohort, individuals with major depressive disor-
der and co-occurring substance use disorders (including 
alcohol) had earlier onset of depression, greater sever-
ity and functional impairment, and higher rates of sui-
cide attempts and completed suicide [3]. Similarly, while 
many individuals with anxiety disorders use alcohol for 
short-term symptom relief, drinking can ultimately make 
anxiety more severe [2, 4]. These associations highlight 
the need to assess alcohol and drug use patterns among 
young adults with mental health problems, in order 
to understand potential symptom exacerbation and 
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medication interaction risks. Assessment could also help 
to identify which individuals may benefit from psychia-
try-based brief interventions to reduce harmful drinking 
patterns, and who should be referred to specialty care 
addiction treatment.
Apart from the potential value of brief interventions, 
screening provides benchmark medical record data at 
intake to help providers track potential changes in drink-
ing over time. Some studies suggest that screening alone 
could help to reduce drinking [6, 7]. In the clinician’s 
guide to identifying and treating drinking problems in 
health care settings, the National Institutes on Alcohol 
Abuse and Alcoholism (NIAAA) recommends asking 
how many times in the past year individuals have had 5 
or more drinks for men and 4 or more for women [8]. In 
2009 Smith et al., reported a sensitivity of 88 % and speci-
ficity 67 % of this cutoff in detecting a current (AUD) in 
a primary care setting [9]. Using the Alcohol Use Disor-
ders Identification Test (AUDIT) as reference, Massey 
et al. [10] reported 96 % sensitivity and 82 % specificity of 
screening question to detect harmful drinking in an alert 
nonpsychotic consult-liaison population. In the present 
study we used a similar cutoff (5+ drinks for both men 
and women) drawn from electronic health record intake 
data in a psychiatry clinic setting to examine prevalence 
and correlates of hazardous drinking in young adults. 
The same cutoff was used for both sexes as this was the 
information available from the data, which was based on 
a graduated frequency measure that did not adjust quan-
tities based on sex.
Although young adults are at high risk for alcohol-
related problems [11], studies evaluating drinking pat-
terns and their association with clinical characteristics 
are lacking. This study evaluated self-reported alcohol use 
patterns and the association between prior-year hazard-
ous drinking and potentially relevant patient characteris-
tics, including gender, age, clinician-assigned psychiatric 
diagnosis, and other substance use in a sample of young 
adults presenting for initial mental health treatment. We 
hypothesized that prior-year hazardous drinking would 
be associated with an AUD diagnosis, with other com-
mon psychiatric diagnoses, in particular, anxiety and 
depression, and with other types of substance use preva-
lent in this population such as tobacco and marijuana.
Methods
Participants and measures
Study participants were adults ages 18–25 seeking psy-
chiatric services in an outpatient clinic in a university 
medical center. This clinic provides a range of assessment 
and treatment services, including medication manage-
ment and individual and group psychotherapy. The clinic 
has no formal services for patients primarily seeking 
alcohol or drug treatment. Individuals seeking such ser-
vices are pre-screened by telephone by clinic staff and 
referred to local specialty care programs.
The sample included all individuals who presented to 
the clinic for initial evaluation between September 14th, 
2005 and June 29th, 2011, were between the ages of 18 
and 25 at intake, and completed routine computerized 
questionnaires, including a self-administered Electronic 
Health Inventory (EHI) [12], Beck Depression Inventory-
II (BDI-II) and a clinical interview. Other than age range 
and intake dates, there were no exclusion criteria.
The EHI was completed on private computers in the 
clinic waiting area. It included questions about demo-
graphic characteristics, current and past medical history, 
and patterns of substance use for alcohol, cannabis and 
tobacco. For each substance, participants were asked if 
they had ever used that substance during their lifetime. 
Positive responses prompted questions on duration and 
frequently of use. Providers received a printed copy of 
the EHI questionnaire results for use in evaluation of 
new patients at intake. The University of California, San 
Francisco Committee on Human Research approved the 
study, including the examination of de-identified records 
of patients who had an initial clinic visit during the study 
time period.
Participants who endorsed any lifetime alcohol or 
cannabis/marijuana use were asked the timing of most 
recent use (in years, months or days) prior to intake. 
Alcohol use questions included usual quantity con-
sumed per occasion (in standard drinks), frequency of 
use in the past 30 days and number of days in the past 
year when 1–2, 3–4, 5–7, and ≥8 drinks were consumed 
on one occasion (graduated frequency method) [13]. 
Combining the responses of any consumption of 5–7 or 
≥8 drinks consumed on one occasion in the past year, 
hazardous drinking was defined for this analysis as any 
past-year consumption of 5 or more drinks on one occa-
sion, consistent with the definition used by the NHIS 
(5+ drinks for both women and men) during the same 
time period [14]. While NIAAA currently recommends 
a different cut-off for hazardous drinking in men (5+) 
and women (4+), data were not available to assess this 
distinction.
Substance use and psychiatric disorder diagnoses
By chart review, we obtained all assigned Diagnostic and 
Statistical Manual of Mental Disorder, Fourth Edition 
Text Revision (DSM-IV-TR) [15] diagnoses listed on each 
participants’ standardized initial intake evaluation form, 
as assigned and documented by the clinician. Blinded to 
responses on the EHI, a study research assistant reviewed 
and coded all listed diagnoses. We coded only definite 
diagnoses, excluding “rule out” diagnoses.
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We coded drug use disorder positive if abuse or 
dependence was diagnosed for the following drugs: 
amphetamine, cannabis, opiates, methamphetamine, 
mushrooms, benzodiazepines, cocaine, stimulants, or 
if polysubstance abuse was diagnosed. Given the young 
age of the sample, disorders in remission would still be 
temporally relatively recent. Therefore, no distinction 
was made between diagnoses in remission or active. We 
coded alcohol use disorder (AUD) positive if alcohol 
abuse or dependence was diagnosed. Likewise, no dis-
tinction was made between diagnoses in remission or still 
active. We coded depressive disorder positive if major 
depressive disorder, dysthymia, or depression not other-
wise specified (NOS) was diagnosed. Similarly, we coded 
an anxiety disorder if anxiety disorder NOS, generalized 
anxiety disorder, social anxiety disorder, panic disorder, 
specific phobia, post-traumatic stress disorder or obses-
sive compulsive disorder was diagnosed. We coded bipo-
lar disorder positive if bipolar affective disorder (BAD) 
type I, II or NOS was diagnosed. We coded psychotic dis-
order positive if schizophrenia, schizoaffective disorder, 
delusional disorder or psychosis NOS was diagnosed. We 
coded attention deficit hyperactivity disorder (ADHD) 
positive if ADHD (inattentive, hyperactive, or combined 
type) or ADHD NOS was diagnosed. We coded eating 
disorder positive if anorexia, bulimia or eating disorder 
NOS was diagnosed.
Analyses
We linked self-reported demographic and substance 
use data from the EHI to diagnostic data from the chart 
review to create a single dataset for analysis. We com-
pared differences in alcohol use rates between men and 
women using the χ2 test, and differences in BDI-II score 
and mean quantity of alcohol consumed between women 
and men using t tests. Similarly, using χ2 tests for cate-
gorical variables and t tests for continuous variable, rates 
of alcohol, tobacco and marijuana use, as well as rates 
of specific psychiatric diagnoses at intake were exam-
ined by prior-year hazardous drinking. Underage alcohol 
use was also examined (rate of any hazardous drinking 
among those ages 18–20 vs. 21–25). Given that partici-
pants could be assigned several diagnoses at intake, indi-
vidual diagnoses were not included in regression models 
(as they were not independent of each other). Instead, we 
assessed diagnostic burden as indicated by the number 
of diagnoses assigned at intake. We used a single logistic 
regression model to test the association between num-
ber of psychiatric diagnoses, any lifetime use of tobacco 
and cannabis, age, race/ethnicity and gender as potential 
predictors of participants reporting any hazardous drink-
ing in the prior year. We used STATA version 13 for all 
analyses.
Results
During the study intake period, 487 new patients between 
the ages of 18–25 years were admitted. The sample was 
racially diverse and predominantly female, and included a 
substantial percentage of students (Table 1).
Lifetime alcohol use was endorsed by 85.4  % of the 
sample, prior year alcohol use was endorsed by 79.8  %, 
and 52.3 % reported prior year hazardous drinking. Fre-
quency of hazardous drinking was: 1–5 times a year 
(22.8 %), 6–11 times a year (11.5 %), about once a month 
(3.3  %), 2 or 3 times a month (7.0  %), once or twice a 
week (6.2  %), 3 or 4 times a week (0.8  %), nearly every 
day (0.5  %). Lifetime marijuana use was endorsed by 
66.7 % of participants and prior year marijuana use was 
endorsed by 48.1 % of the sample. There were no signifi-
cant gender differences in any of the above rates. AUD 
diagnoses were present in 8.2 % of the sample, and were 
twice as prevalent among women (10.3 %) compared to 
men (4.2 %) (χ2 = 5.2, p = 0.02). Participants over age 21 
(N = 313) endorsed significantly greater prior-year haz-
ardous drinking than those under 21 (N = 174) (58.8 % 
vs. 41.2 % respectively; χ2 = 14.5, p < 0.001) (not shown).
Table 1 Demographic characteristics and  occupational 
status of  adults ages 18–25 seeking outpatient mental 
health treatment (N = 487)
Variables Mean (SD) or %
Gender (%)
 Men 33.9
 Women 66.1
Age (mean, SD) 22.2 (±2.3)
 Men 21.9 (±2.4)
 Women 22.3 (±2.3)
Race (%)
 Asian 15.2
 Black 2.5
 White 62.6
 Other 19.7
Hispanic origin (%) 9.9
Education (%)
 High school grade 7–12 4.6
 High school graduate or GED 47.3
 Completed technical training 3.2
 College graduate 27.8
 In or completed graduate training 17.1
Occupational status (%)
 Student 44.8
 Employed (full or part-time) 31.7
 Unemployed 21.5
 Disability 2.0
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The most prevalent psychiatric diagnoses at intake 
were depression (55  %) and anxiety disorders (43.3  %) 
with no gender differences. BDI-II scores were avail-
able for 395 participants. Overall mean BDI-II score 
was 22.2 (SD = 10.8), indicative of moderate depression, 
with a significant difference between men (mean = 18.6, 
SD = 10.8) and women (mean = 24.1, SD = 13.4) (p ≤ 
0.001) (not shown).
Overall, rates and frequency of alcohol, tobacco and 
marijuana use were significantly greater in those who 
endorsed hazardous drinking in the prior 12  months 
compared to those who didn’t (Table 2). Rates of AUDs 
were four times greater among those who endorsed 
hazardous drinking in the prior 12  months, compared 
to those who didn’t (Table  2). Rate of psychotic disor-
ders among those who endorsed prior 12-month haz-
ardous drinking were less frequent compared to those 
who denied hazardous drinking in the prior 12 months. 
There were no significant differences in the rates of other 
psychiatric disorders among those who did and those 
who did not endorse hazardous drinking in the prior 
12 months.
Logistic regression analysis was used to examine pre-
dictors of prior-year hazardous drinking (Table  3). The 
single model included number of diagnoses at intake, age, 
gender, race, and any lifetime marijuana or tobacco use. 
Variables positively associated with prior-year hazard-
ous drinking included lifetime marijuana use (OR 3.30, 
p < 0.001; 95 % CI 2.05, 5.28), lifetime tobacco use (OR 
1.88, p =  0.004; 95  % CI 1.22, 2.90) and older age (OR 
1.18 per year, p  <  0.001; 95  % CI 1.08; 1.29) (Table  3). 
Results from sensitivity analyses using prior-year canna-
bis and smoking measures (which occurred during the 
same time frame as the hazardous drinking) were similar, 
and the significance of the measures in predicting prior-
year hazardous drinking did not change (not shown).
Table 2 Substance use patterns and psychiatric diagnoses of young adults ages 18–25 seeking outpatient mental health 
treatment by hazardous drinking status
Significant differences appear in italics
Variable Hazardous drinking in the prior 12 months
Total N = 487
No hazardous drinking
N = 232 (47.6 %)
≥1 days of hazardous drinking
N = 255 (52.3 %)
p value
Mean or % SD Mean or % SD
Alcohol use (%)
 Lifetime 69.4 100 <0.0001
 Prior year 59.1 98.8 <0.0001
 Prior month 37.9 87.8 <0.0001
 Usual quantity of drinks consumed per occasion 0.9 ±1.1 3.1 ±1.9 <0.0001
 Number of days alcohol was consumed in prior 30 days 2.2 ±4.5 6.4 ±6.5 <0.0001
Tobacco use (%)
 Lifetime 38.8 65.9 <0.0001
 Prior year 22.4 51.0 <0.0001
 Prior month 21.1 38.8 <0.0001
Marijuana use (%)
 Lifetime 49.6 82.4 <0.0001
 Prior year 29.7 64.7 <0.0001
 Prior month 16.0 40.0 <0.0001
Psychiatric diagnoses at initial intake (%)
 Depressive disorder 53.9 56.1 0.6261
 Anxiety disorder 42.2 44.3 0.6448
 Bipolar disorder 11.6 17.3 0.0794
 Eating disorders 14.2 11.8 0.4193
 Psychotic disorder 16.4 8.24 0.0059
 Drug use disorder (excluding tobacco and alcohol) 5.17 9.41 0.0741
 Alcohol use disorder 3.02 12.9 0.0001
 Attention deficit disorder 7.33 6.67 0.7750
 PTSD 6.47 4.31 0.2914
 Mean number of diagnoses at initial intake 2.02 ±1.1 2.36 ±1.3 0.0300
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Discussion
This study examined the relationship of prior-year haz-
ardous drinking to patterns of alcohol, tobacco and can-
nabis use, as well as psychiatry diagnoses, in a young 
adult outpatient psychiatry sample. In this treatment-
seeking sample, cannabis and tobacco use as well as older 
age were significant predictors of hazardous drinking.
These results highlight the high rates of hazardous drink-
ing in a young adult population seeking mental health treat-
ment, and the need for systematic screening in this group. 
The levels of prior-year hazardous drinking in our study 
were approximately twice as high in men (53.3 vs. 23.7 %) 
and five times higher in women (51.9 vs. 10.3  %) than in 
individuals of the same age, during the same time frame 
in the National Health Interview Survey (NHIS) [14]. Our 
sample also included a substantial proportion of students, 
we found comparable rates to those seen in college students 
(approximately 45 % prior-month hazardous drinking) [16]. 
These rates are also higher than those seen in a study of 
hazardous drinking among adults with moderate or greater 
depression symptoms from the same clinic setting [17]. 
This sample (N = 1183) ranged in age from 18 to 91, with 
a mean age of 42.2 (SD = 14.7) 47.5 % of men and 32.5 % 
of women reported prior-year hazardous drinking, com-
pared to 53.3 and 51.9 % for men and women in our young 
adult sample. In addition, younger age was an independent 
predictor of hazardous drinking in this larger clinic sample. 
Thus, the clinical setting, student composition and age of 
participants may help to explain our findings.
Based on this same previous study in the psychiatry 
clinic with a mean age of 42.2 [16], the most common 
primary psychiatric diagnosis assigned to patients follow-
ing their first visit was major depressive disorder (48.4 %), 
followed by bipolar disorder (14.8  %), anxiety disorders 
(11.2  %), depressive disorder not otherwise specified 
(7.5  %), mood disorder not otherwise specified (4.3  %), 
adjustment disorders (4.3 %), schizophrenia (1.2 %), and 
9.1 % all other diagnoses combined. For most diagnoses, 
rates were similar to those in the current sample. The 
exception is anxiety diagnoses, which were identified at a 
higher rate in the current sample. A potential explanation 
for the difference is sample selection (participants scored 
10+ on the BDI-II) as well as the way in which diagnoses 
were identified. The prior study measured only primary 
diagnoses, while the current young adult study used 
manual chart review to include all diagnoses assigned by 
providers.
Although rate of AUD assignment was low relative 
to the rate of prior-year hazardous drinking, especially 
among men, any self-reported prior-year hazardous 
drinking was associated with a fourfold higher rate of an 
AUD diagnosis. These findings highlight the relevance of 
hazardous drinking screening among young adults seek-
ing mental health treatment as a component of psychi-
atric evaluation and treatment [2, 3, 5] and an indicator 
of a possible AUD. It is noteworthy that in our sample 
AUD diagnoses were twice as prevalent in woman as in 
men. This is in contrast to many prior epidemiological 
studies, including the National Epidemiologic Survey on 
Alcohol and Related Conditions (NESARC) [18], which 
found rates of alcohol abuse and dependence to be a lit-
tle more than double in men compared to women. It is 
possible that, rather than reflecting actual gender differ-
ences in AUD diagnoses, the higher rate of AUD among 
women in our sample reflects a greater concern from 
providers regarding problematic drinking in treatment 
seeking young women than in young men. This pattern 
has previously been described in a study of the Veterans 
Health Administration, which found race and gender dif-
ferences among VA patients with clinically recognized 
AUDs [19]. That study outlines the importance of validat-
ing diagnoses against structured gold-standard clinical 
assessments to better understand whether providers are 
over or under-identifying AUDs.
Analyses of the relationship of psychiatric diagnoses 
to hazardous drinking indicated that, aside from AUDs, 
no single psychiatric disorder was particularly associated 
with increased rates of hazardous drinking. The finding 
of hazardous drinking being associated with lower rates 
of psychotic disorder diagnosis was not anticipated. 
There is a large body of data regarding comorbid sub-
stance abuse and psychosis. For example, psychosis has 
been associated with frequent cannabis use in national 
surveys [20]. Similarly, several studies have described 
comorbid AUDs in patients with psychosis [21, 22]. It is 
therefore unexpected that among all diagnoses, hazard-
ous drinking would be negatively associated with psy-
chotic disorder. One possible explanation is that, given 
Table 3 Factors associated with  prior-year hazardous 
drinking in  young adults seeking outpatient psychiatric 
services (N = 487)
Results are from a single multivariate logistic regression
Significant differences appear in italics
Predictor OR p value 95 % CI
Number of psychiatric diagnoses at intake 1.06 0.459 0.90–1.25
Lifetime cannabis use 3.30 <0.001 2.05–5.28
Lifetime tobacco use 1.88 0.004 1.22–2.90
Age in years 1.18 <0.001 1.08–1.29
Female gender 0.98 0.932 0.64–1.50
Race (reference: white)
 Black 0.52 0.372 0.13–2.17
 Asian 0.43 0.007 0.23–0.80
 Other 1.20 0.470 0.73–2.00
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that all participants were seeking outpatient mental 
health treatment, the variability in the sample was more 
limited than in those seen in other studies.
Study findings have important implications for clini-
cal practice. Screening for hazardous drinking should 
be conducted with all psychiatric patients, regard-
less of diagnosis. The finding that any marijuana use 
was associated with 3.3 fold greater odds of prior-year 
hazardous drinking is also noteworthy. This finding 
was consistent with previous literature in college stu-
dents, which found that those who use both marijuana 
and alcohol are more likely to experience alcohol and 
other drug problems, including higher mean number of 
drinks per occasion [23]. Helping clinicians be aware of 
the frequency of co-occurring marijuana use with haz-
ardous drinking may represent an additional opportu-
nity to improve identification of alcohol and other drug 
problems.
Mental health clinics are important settings in which 
to address hazardous drinking and identify AUDs. Indi-
viduals with AUDs are more likely to seek care in mental 
health settings than in specialized addiction treatment 
programs [24]. While effective interventions to reduce 
co-occurring alcohol problems exist, providers in psy-
chiatry clinics often fail to identify warning signs of prob-
lematic drinking and overlook opportunities to intervene 
[25, 26]. Interventions such as motivational interview-
ing could be important supplements to mental health 
treatment [27–29]. The Screening, Brief Intervention 
and Referral to Treatment (SBIRT) model promoted by 
the U.S. Substance Abuse and Mental Health Services 
Administration (SAMHSA) [30] is another example of 
a potential supplement to existing mental health care. 
SBIRT is a public health-based approach to early inter-
vention for at-risk individuals identified in primary care 
and other health settings. Implementing these interven-
tions in general psychiatric treatment for young adults, as 
well as identifying and referring AUDs to specialty addic-
tion treatment when indicated, could help reduce haz-
ardous drinking and improve overall patient care.
Limitations
This study had several limitations. While computer-
ized self-report measures are valid, under-reporting of 
alcohol and cannabis use by patients would make our 
prevalence rates conservative. In addition, the clinic 
that served as the study site routinely referred patients 
primarily seeking care for alcohol and drug problems to 
specialty care treatment programs, which may also lead 
to lower prevalence rates of hazardous drinking in our 
population compared to some other psychiatric service 
settings. Similarly, our study used provider-assigned 
diagnoses and did not systematically assess AUDs using 
structured interviews, resulting in potential under- and/
or over-estimate of AUD rates and hindering our ability 
to determine the sensitivity and specificity of prior-year 
hazardous drinking as a predictor of AUDs. In addition, 
the lack of distinction between active AUD or substance 
use disorder diagnoses and those in remission limits 
the correlation of hazardous drinking in our study to 
any lifetime AUD or substance use disorder diagnoses. 
However, the low number of clinician-assigned AUDs 
in the context of hazardous drinking remains notewor-
thy. Lastly, using a lower cutoff for hazardous drinking 
for women than for men (4 drinks per occasion rather 
than 5), would increase sensitivity of “at risk” drinking 
in this group, and is often used in population-based and 
clinical studies. The use of a higher cutoff in this study 
may make our estimates of hazardous drinking among 
women conservative.
Conclusions
This study examined the extent of hazardous drink-
ing, alcohol and other substance use patterns, pro-
vider-assigned AUDs, and co-occurring psychiatric 
disorders among young adults in an outpatient psy-
chiatry clinic. Prior-year hazardous drinking rates for 
both men and women were substantially higher than 
those found in studies of young adults in the general 
population. Lifetime marijuana use and tobacco use 
significantly predicted prior-year hazardous drinking. 
There was a strong association of prior-year hazardous 
drinking with a clinician-assigned AUD, even though 
overall rate of AUD diagnosis was relatively low. Out-
patient mental health service settings offer an excellent 
opportunity for early identification and intervention to 
reduce alcohol and other substance use among young 
adults.
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